UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Single Infrared Spectrum Enables Simultaneous Identification of (Bio)Chemical Nature and Particle Size of Microorganisms and Synthetic Microplastic Beads

Analytical chemistry (Washington), 2023-12, Vol.95 (48), p.17826-17833

2023

Volltextzugriff (PDF)

Editorial for “Deep Learning With an Attention Mechanism for Differentiating the Origin of Brain Metastasis Using MR Images”

Journal of magnetic resonance imaging, 2023-11, Vol.58 (5), p.1636-1637

2023

Volltextzugriff (PDF)

Editorial for "Deep Learning With an Attention Mechanism for Differentiating the Origin of Brain Metastasis Using MR Images: A Multicenter Study"

Journal of magnetic resonance imaging, 2023-11

2023

Volltextzugriff (PDF)

Enhancement of tidal generators by superconducting energy storage and Jaya‐based sliding‐mode controller

International journal of energy research, 2020-11, Vol.44 (14), p.11658-11675

Othman, Ahmed M.

2020

Volltextzugriff (PDF)

Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double‐Blind, Randomized Controlled Trial

Arthritis & rheumatology (Hoboken, N.J.), 2019-11, Vol.71 (11), p.1788-1800

2019

Volltextzugriff (PDF)

Clinical Pharmacokinetics and Pharmacodynamics of Risankizumab in Psoriasis Patients

Clinical pharmacokinetics, 2020-03, Vol.59 (3), p.311-326

2020

Volltextzugriff (PDF)

Parallel indirect time-of-flight ranging using on-chip dual-frequency combs

Applied optics (2004), 2024-08, Vol.63 (22), p.5917

2024

Volltextzugriff (PDF)

Deep Learning Reconstruction for Accelerated Spine MRI: Prospective Analysis of Interchangeability

Radiology, 2023-03, Vol.306 (3), p.e212922-e212922

2023

Volltextzugriff (PDF)

Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus

Clinical pharmacokinetics, 2020-03, Vol.59 (3), p.335-347

2020

Volltextzugriff (PDF)

Feasibility of Using Population Pharmacokinetics‐Based Virtual Control Groups in Organ Impairment Studies

Journal of clinical pharmacology, 2024-06, Vol.64 (6), p.713-718

2024

Volltextzugriff (PDF)

Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn’s Disease: Analyses of Phase I and II Trials

Clinical pharmacokinetics, 2019-03, Vol.58 (3), p.375-387

2019

Volltextzugriff (PDF)

A Phase IIb Study of ABT‐494, a Selective JAK‐1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti–Tumor Necrosis Factor Therapy

Arthritis & rheumatology (Hoboken, N.J.), 2016-12, Vol.68 (12), p.2867-2877

2016

Volltextzugriff (PDF)

Population Pharmacokinetics of Risankizumab in Healthy Volunteers and Subjects with Moderate to Severe Plaque Psoriasis: Integrated Analyses of Phase I–III Clinical Trials

Clinical pharmacokinetics, 2019-10, Vol.58 (10), p.1309-1321

2019

Volltextzugriff (PDF)

Lack of Effect of 12-Week Treatment with Risankizumab on the Pharmacokinetics of Cytochrome P450 Probe Substrates in Patients with Moderate to Severe Chronic Plaque Psoriasis

Clinical pharmacokinetics, 2019-06, Vol.58 (6), p.805-814

2019

Volltextzugriff (PDF)

Dual energy computed tomography virtual monoenergetic imaging: technique and clinical applications

British journal of radiology, 2019-04, Vol.92 (1098), p.20180546

2019

Volltextzugriff (PDF)

Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist

Clinical pharmacokinetics, 2023-04, Vol.62 (4), p.609-621

2023

Volltextzugriff (PDF)

Clinical Pharmacokinetics of Upadacitinib: Review of Data Relevant to the Rheumatoid Arthritis Indication

Clinical pharmacokinetics, 2020-05, Vol.59 (5), p.531-544

2020

Volltextzugriff (PDF)

Population Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I and II Clinical Trials

Clinical pharmacokinetics, 2018-08, Vol.57 (8), p.977-988

2018

Volltextzugriff (PDF)

Exposure–Response Relationships for the Efficacy and Safety of Risankizumab in Japanese Subjects with Psoriasis

Clinical pharmacokinetics, 2020-05, Vol.59 (5), p.575-589

2020

Volltextzugriff (PDF)

Efficacy and Safety of ABT‐494, a Selective JAK‐1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Arthritis & rheumatology (Hoboken, N.J.), 2016-12, Vol.68 (12), p.2857-2866

2016

Volltextzugriff (PDF)

Population Pharmacokinetics of the TNF‐α and IL‐17A Dual‐Variable Domain Antibody ABT‐122 in Healthy Volunteers and Subjects With Psoriatic or Rheumatoid Arthritis: Analysis of Phase 1 and 2 Clinical Trials

Journal of clinical pharmacology, 2018-06, Vol.58 (6), p.803-813

2018

Volltextzugriff (PDF)

A disposable optofluidic micro-transmission cell with tailorable length for Fourier-transform infrared spectroscopy of biological fluids

Analytical methods, 2024-01, Vol.16 (2), p.262-268

2024

Volltextzugriff (PDF)

Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients With Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis

Journal of clinical pharmacology, 2019-12, Vol.59 (12), p.1656-1668

2019

Volltextzugriff (PDF)

Scalloped pattern deposition during the spreading and drying of polymer droplets

Soft matter, 2023-11, Vol.19 (44), p.8483-8492

2023

Volltextzugriff (PDF)

Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis

Clinical pharmacokinetics, 2016-12, Vol.55 (12), p.1547-1558

2016

Volltextzugriff (PDF)

1 – 25 von 2.272

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.256)
Mit Volltextzugriff
(1.367)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Single Infrared Spectrum Enables Simultaneous Identification of (Bio)Chemical Nature and Particle Size of Microorganisms and Synthetic Microplastic Beads

Editorial for “Deep Learning With an Attention Mechanism for Differentiating the Origin of Brain Metastasis Using MR Images”

Editorial for "Deep Learning With an Attention Mechanism for Differentiating the Origin of Brain Metastasis Using MR Images: A Multicenter Study"

Enhancement of tidal generators by superconducting energy storage and Jaya‐based sliding‐mode controller

Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double‐Blind, Randomized Controlled Trial

Clinical Pharmacokinetics and Pharmacodynamics of Risankizumab in Psoriasis Patients

Parallel indirect time-of-flight ranging using on-chip dual-frequency combs

Deep Learning Reconstruction for Accelerated Spine MRI: Prospective Analysis of Interchangeability

Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus

Feasibility of Using Population Pharmacokinetics‐Based Virtual Control Groups in Organ Impairment Studies

Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn’s Disease: Analyses of Phase I and II Trials

A Phase IIb Study of ABT‐494, a Selective JAK‐1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti–Tumor Necrosis Factor Therapy

Population Pharmacokinetics of Risankizumab in Healthy Volunteers and Subjects with Moderate to Severe Plaque Psoriasis: Integrated Analyses of Phase I–III Clinical Trials

Lack of Effect of 12-Week Treatment with Risankizumab on the Pharmacokinetics of Cytochrome P450 Probe Substrates in Patients with Moderate to Severe Chronic Plaque Psoriasis

Dual energy computed tomography virtual monoenergetic imaging: technique and clinical applications

Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist

Clinical Pharmacokinetics of Upadacitinib: Review of Data Relevant to the Rheumatoid Arthritis Indication

Population Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I and II Clinical Trials

Exposure–Response Relationships for the Efficacy and Safety of Risankizumab in Japanese Subjects with Psoriasis

Efficacy and Safety of ABT‐494, a Selective JAK‐1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Population Pharmacokinetics of the TNF‐α and IL‐17A Dual‐Variable Domain Antibody ABT‐122 in Healthy Volunteers and Subjects With Psoriatic or Rheumatoid Arthritis: Analysis of Phase 1 and 2 Clinical Trials

A disposable optofluidic micro-transmission cell with tailorable length for Fourier-transform infrared spectroscopy of biological fluids

Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients With Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis

Scalloped pattern deposition during the spreading and drying of polymer droplets

Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis

Aktive Filter

Suchergebnisse filtern